Cargando…
Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
BACKGROUND: Leishmaniasis remains a worldwide public health problem. The limited therapeutic options, drug toxicity and reports of resistance, reinforce the need for the development of new treatment options. Previously, we showed that 17-(allylamino)-17-demethoxygeldanamycin (17-AAG), a Heat Shock P...
Autores principales: | Santos, Diego M., Petersen, Antonio L. O. A., Celes, Fabiana S., Borges, Valeria M., Veras, Patricia S. T., de Oliveira, Camila I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207694/ https://www.ncbi.nlm.nih.gov/pubmed/25340794 http://dx.doi.org/10.1371/journal.pntd.0003275 |
Ejemplares similares
-
Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011) -
Canine Cutaneous Leishmaniasis: Dissemination and Tissue Tropism of Genetically Distinct Leishmania (Viannia) braziliensis Populations
por: de Oliveira, Guilherme Marx, et al.
Publicado: (2013) -
A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
por: Zauli, Rogéria C, et al.
Publicado: (2012) -
Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis
por: Valdivia, Hugo O., et al.
Publicado: (2015) -
Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon
por: Brilhante, Andreia Fernandes, et al.
Publicado: (2019)